Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03076008 · ClinicalTrials.gov registry record

The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction

A clinical trial of Patellar Dislocation, sponsored by University of Minnesota.

Active
Registry status
201
Enrollment target
1
Study location

NCT03076008 is a study of Patellar Dislocation that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 201 participants, below the 329-participant average among 3 other Patellar Dislocation trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03076008, a study of Patellar Dislocation, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
201 participants
Enrollment target
1
Study location

Study Summary

The investigators plan to perform a prospective observational cohort study of patients undergoing MPFL reconstruction for the treatment of episodic patellar instability in the absence of significant degenerative disease. The investigators will follow these study subjects for a minimum of two years to monitor their functional and clinical outcome.

Conditions Studied

Interventions

  • OTHER Observational

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2016-10-01
Est. Completion 2026-06-30

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT03076008

The ClinicalTrials.gov registry entry for NCT03076008 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 3 other Patellar Dislocation trials with a reported enrollment target (39% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Patellar Dislocation appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.

NCT03076008 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03076008 about?

NCT03076008 is a clinical study titled "The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction". The investigators plan to perform a prospective observational cohort study of patients undergoing MPFL reconstruction for the treatment of episodic patellar instability in the absence of significant degenerative disease. The investigators will follow these study subjects for a minimum of two years t...

What is the current status of trial NCT03076008?

This trial is currently active not recruiting. The enrollment target is 201 participants. The study started on 2016-10-01. Estimated completion is 2026-06-30.

What conditions does trial NCT03076008 study?

This clinical trial studies the following conditions: Patellar Dislocation.

What interventions are being tested in trial NCT03076008?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT03076008?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03076008 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patellar Dislocation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.